DNA Energy, Inc. is relaunching its energy drink brand in Q2 2017 with three new natural flavors. The company aims to build shareholder value through distribution expansion and potential acquisitions. It provides an overview of the large and growing US energy drink market, DNA's product specifications and 2017 launch plans for South Florida. It also presents financial projections, management details, proposed offering terms, and use of proceeds to fund the 2017 relaunch.

1. Human Performance Liquified
2017 Re-Launch Presentation

2. Forward Looking Statement
This presentation includes forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Such forward-looking statements involve known and unknown
risks, uncertainties and other factors which may cause actual
results, performance or achievements of the Company to be
materially different from any future results, performance or
achievements expressed or implied by such forward-looking
statements. Such factors include the Company’s ability to
successfully distribute its products, failure to successfully
complete the development of new or enhanced products, the
Company’s ability to meet its future capital needs, the success of
competitive products, fluctuations in costs, changes in consumer
preferences and other items described in the Company’s PPM.
The Company undertakes no obligation to update any
statements in this presentation.

3. Introduction
• DNA Energy, Inc (DNAX) is a publicly held beverage
brand company focusing on the Energy Drink Category.
• DNA Energy, Inc. (DNAX) was launched in 2007 and on
the market until 2015 Generating $10-$15m In revenue
with sales in 20+ States
• DNA Energy, Inc. (DNAX) appointed Adrian McKensie
CEO in February 2016
• DNA Energy, Inc. (DNAX) anticipates relaunching three
reformulated and natural flavors of DNA Energy drink
during the 2nd quarter of 2017.

4. Mission Statement
DNA Energy’s Mission is to build shareholder value through
The relaunch of DNA Energy Drink
Developing a Distribution Network
Developing Chain Relationship
Acquisitions

5. Energy Drink Category Overview
• Mintel projected the US energy drink market to hit $10.8 billion in 2015
• Based on a recent survey, global research firm Mintel expects the US
energy drink market to grow by an estimated 52% from 2014 to 2019.
• Packaged Facts Research estimates that energy drinks sales
breakdown as follows:
• 59% convenience stores
• 13% mass merchandisers (Wal-Mart and Target)
• 10% supermarkets
• 5% club stores/warehouse (Costco Sams, BJ’s,etc)
• 2% drug stores (CVS and Walgreen’s, etc)
• 11% is made up of all other categories, (Dollar stores, etc)

6. About DNA Energy
• DNA Energy offers consumers a proprietary blast of
Vitamin B in 3 Flavors:
Cellular Citrus Cryo Berry Moleculalr Melon
Winner of two consecutive World Beverage Competition Platinum “Best of Show” awards

7. DNA Retail and Distributor Pricing
• Front Line Buy 2 for $3.00
• Price to Consumer $2.29 $1.50
• Unit Price to Retailer $1.33 $ .89
• Case Price to Retailer $32.00 $21.33
• Retailer GP/Unit $ .86 $ .61
• Retailer GP/Case $20.64 $14.64
• Price to Distributor $24.00 $16.00
• Distributor GP $ 8.00 $ 5.33
• Distributor Margin 25% 25%

8. Product Specifications
Human Performance Liquefied
ITEM DESCRIPTION
Item
UPC
Case
UPC
Case
Pack
Case
Weight
Case
Cube
Tie/High
Case
Dimensions
L" x W" x H"
Pallet
Truck
Load
Cases
Truck
Load
Pallet
Weight
Truck
Load
Weight
ENERGY DRINK
ORIGINAL
8 91553 001367 00891553001374 24 28 lbs 0.62 10/7 16 "x10.625"x 6.25" 21 1,470 2,005 lbs 42,105
ENERGY DRINK
ZERO SUGAR FREE
CELLULAR CITRUS
8 91553 001022 00891553001053 24 26.5 lbs. 0.62 10/7 16 "x10.625"x 6.25 22 1,540 1,900 lbs 41,800
ENERGY DRINK
MOLECULAR MELON
8 91553 001480 00891553001497 24 28 lbs. 0.62 10/7 16 "x10.625"x 6.25 21 1,470 2,005 lbs 42,105
ENERGY DRINK
CELLULAR CITRUS
8 91553 001503 00891553001510 24 28 lbs 0.62 10/7 16 "x10.625"x 6.25 21 1,470 2,005 lbs 42,105
ENERGY DRINK
CRYO BERRY
8 91553 001466 00891553001473
24 28 lbs 0.62 10/7 16 "x10.625"x 6.25 21 1,470 2,005 lbs 42,105

9. 2017 South Florida Launch Plan
April 1-15 2017
Complete Production Run
Hire South Florida Sales Reps and Drivers April1
April 15 -Sept 31 2017: South Florida
Sell DNA Independent South Florida Retail Accounts
In Store Merchandising
In Store Demos
Guerrilla Marketing (Beach & Event Sampling)
Identify and Sponsor Monthly Events

10. 2017 South Florida Launch Plan (cont)
October – December 2017
Appoint South Florida 3rd Party Distributors
Interview other Florida 3rd Party Distributors
Targeting Anheuser-Busch Dist. network
Present DNA to Florida Chains
Identify Target Southeast Markets for 2018
Develop 2018 Budget

11. Legend
Start
On Order
Finish/Deliver
9-Jan 16-Jan 23-Jan 30-Jan 6-Feb 13-Feb 20-Feb 27-Feb 6-Mar 13-Mar 20-Mar 27-Mar 3-Apr
Co-Packers
Quote/Visit Miami
Quote/Visit Cott
Quote/Visit/Other
Finalize Co-Packer
Production Run
Can Graphics
Facelift
Address
UPC Codes
NLEA
Order Cans
Deliver Cans
Flavor Formula
Final Approval
Formula
Finalize COG
Submit to Lab
Lab Work Complete
Order Ingredients
Ingredients
Delivered
POS Design
Static Cling
Sell Sheet
Place Order
Print

12. Management
Adrian McKensie, Chief Executive Officer has a long-
standing track record of business development,
finance, and marketing experience. After graduating
with a Bachelor's degree in Economics from the
University of Western Ontario, he has spent the last 16
plus years in finance, marketing and corporate
management. He has helped build, worked for and
invested into a diverse mixture of public businesses
including bio tech, social media app development and
beverage companies. Mr. McKenzie will focus on
reestablishing and building a successful brand,
engaging new investors, shareholder building and new
product development.

13. Proposed Offering
Amount: $500,000 (up to 50% increase to $750,000)
Security: Common Stock
Unit Price: No Minimum
Offering: 5,000,000,000 shares (up to 50% increase to
7,500,000,000)
DNA Brands, Inc. (the “Company”) is offering 5,000,000,000 shares of its
common stock, par value $.00001 per share (the “Common Stock”) at a
purchase price of US $0.0001 per share (the “Purchase Price”) on a strictly
confidential basis to “accredited investors” (the “Investors”) in transactions
exempt from registration under Rule 506 of Regulation D promulgated by the
United States Securities and Exchange Commission pursuant to the Securities
Act of 1933, as amended (the “Securities Act”). The Company reserves the
right to increase the size of the Offering by up to an additional 2,500,000,000
shares of Common Stock. Potential investors will receive the Company’s
Private Placement Memorandum with subscription documents for review and
execution.

14. Use of Proceeds
Sources Amount
New Capital
Requirement for 2017 South Florida DNA Product Re-Launch $500,000
Total $500,000
Uses
Reformulation & Lab Analysis $ 10,000
Design (Can, POS, wearable and presentation design) $ 20,000
Aluminum 3 flavors x 6224 cases $ 70,000
Ingredients 3 flavors x 6224cases $ 70,000
Co-packing Fee (to include tray and shrink) 3 cases x 6000 cases $ 70,000
Inbound freight, Outbound freight and Storage $ 30,000
POS Production (Static Cling, Banners, Posters) $ 15,000
Wearables Production (Hats and T-Shirts) $ 15,000
Sampling, Events other marketing $ 50,000
G&A
$150,000
Total $500,000

15. Projected Income Statement
Consolidated 2017 2018 2019
Total Revenue $476,284 $1,671,840 $2,317,680
Cost of Goods $323,996 $1,086,696 $1,390,608
Gross Profit $152,288 $585,144 $927,072
Total Operating $446,126 $697,259 $876,155
EBITDA ($293,883) ($112,115) $50,917
The financial projections reflect numerous assumptions including industry performance, general business and economic conditions and other matters, most of
which are beyond the control of DNAX. While the projections were prepared in good faith and the assumptions, when considered on an overall basis, are
believed to be reasonable in light of the current circumstances, it is important to note that there can be no assurance that such assumptions will be realized,
and investors must make their own determinations as to the reasonableness of such assumptions and the reliability of the projections. Therefore, although the
financial projections are presented with numerical specificity, the actual results achieved during the financial projection period will vary and some of the
variations could be material. Accordingly, no representation can be or is being made with respect to the accuracy of the financial projections or the ability of
DNAX to achieve the projected results of operations. Investors are encouraged to Refer to the “Risk Factors” in the documents the Company files from time to
time with the Securities and Exchange Commission. www.sec.gov.

16. Investment Highlights
Management has strong Public Company and Financial
Industry experience
DNA Energy Brand well known in US Beverage Industry
now active in the beverage category
Energy Drink Category among the largest and still growing
faster than most other categories.
DNA Energy, Inc. poised for additional acquisitions and
market cap growth.

17. Market Data
SYMBOL DNAX
Shares Outstanding 12.5B A/O 1/20/17
CONTACT:
Adrian McKensie
adrian@dnabrandsinc.com
(561) 654-5722